Anzchem’s parent company SPI Pharma offers innovative formulations of orally disintegrating tablets and powder products. With the optimal combination of high-quality ingredients and unparalleled expertise, we can solve even the most challenging formulation problems. Our full spectrum of orally disintegrating tablet products, services, and technologies support every stage of our cutsomer’s product life cycle.
SPI Pharma has commissioned a full-fledged drug development and testing centre (IDC) in Bangalore, India. IDC utilizes state-of-the-art formulation and analytical equipment to enable finished product development in various dosage forms. This allows ‘Speed to Market’ customized drug development projects using several of its proprietary excipients and delivery platforms such as Pharmaburst, Pharmasperse and Pharmachew. For further information on Drug Delivery Systems, please visit the SPI Pharma website.